BA
The Boeing Company
BA's outlook is improving, though it still trails on the overall score.
MYRG
MYR Group Inc.
MYRG has the edge over BA overall, supported by stronger modeled upside and stronger valuation.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
MYRG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
MYRG's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over MYRG in the historical PE scenario, which offers more potential upside but is not a forecast.
MYRG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $214 | -23% |
| Forward | 19x | $278 | — |
| Current | 23x | $278 | — |
| Fair | 24x | $300 | +7.6% |
| Expensive | 42x | $513 | +84% |
Historical ranges are pointers, not guarantees.
MYRG's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
MYRG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for MYRG, with profitability improving. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
MYRG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.56 | +18% |
| Q3 2026 | $12.31 | +100% |
| Q2 2026 | $10.54 | +121% |
| Q1 2026 | $9.07 | +320% |
| Q4 2025 | $7.53 | +311% |
| Q3 2025 | $6.17 | +172% |
| Q2 2025 | $4.77 | +64% |
| Q1 2025 | $2.16 | -58% |
| Q4 2024 | $1.83 | -66% |
MYRG has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over MYRG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
MYRG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +32% |
| Q2 2026 | $1.1B | +20% |
| Q1 2026 | $1B | +20% |
| Q4 2025 | $973.5M | +17% |
| Q3 2025 | $950.4M | +7% |
| Q2 2025 | $900.3M | +8.6% |
| Q1 2025 | $833.6M | +2.2% |
| Q4 2024 | $829.8M | -17% |
MYRG's revenue has grown year over year for seven quarters in a row: $1.3B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.8% | +1.9 points |
| Q2 2026 | 6.3% | +1.9 points |
| Q1 2026 | 6.5% | +2.4 points |
| Q4 2025 | 4.8% | +1.2 points |
| Q3 2025 | 4.9% | +2.6 points |
| Q2 2025 | 4.4% | +6.9 points |
| Q1 2025 | 4.1% | +1.1 points |
| Q4 2024 | 3.6% | -0.1 points |
MYRG has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over MYRG on cash flow, with more consistent year-over-year improvement.
MYRG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | -86% |
| Q2 2026 | -$25.6M | -320% |
| Q1 2026 | $68.6M | -2.3% |
| Q4 2025 | $84.9M | +863% |
| Q3 2025 | $65.4M | +264% |
| Q2 2025 | $11.6M | +365% |
| Q1 2025 | $70.2M | +$88.3M |
| Q4 2024 | $8.8M | -59% |
MYRG generated $137M in free cash flow over the past year, down 12% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
MYRG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -10K shares |
| 1 year | +0.6% | +90K shares |
| 3 years | -6.6% | -1.1M shares |
| 5 years | -8.4% | -1.4M shares |
| Available history | -5.9% | -978K shares |
MYRG has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $75M |
| Q4 2024 | — |
MYRG has spent almost nothing on buybacks in the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
MYRG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
MYRG has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
MYRG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 27.3 | Neutral |
MYRG's weekly RSI is 42 (neutral) and its Stochastic is 27 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over MYRG on valuation relative to its sector.
MYRG PE vs Industrials Sector
| Metric | MYRG | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 6% below |
| PE % | 44 | 58 | 14 pts below |
MYRG is trading at 23x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MYRG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $283.5 | 1.8% below |
| 20 week MA | $317.9 | 12% below |
| 50 week MA | $319.0 | 13% below |
| 100 week MA | $242.7 | 15% above |
| 200 week MA | $188.7 | 48% above |
MYRG has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
MYRG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.1 | $60.4 | +88% |
| 2021 | $60.4 | $106.9 | +77% |
| 2022 | $106.9 | $90.3 | -16% |
| 2023 | $90.3 | $144.6 | +60% |
| 2024 | $144.6 | $150.1 | +3.8% |
| 2025 | $150.1 | $225.1 | +50% |
| 2026 YTD | $225.1 | $278.4 | +24% |
MYRG has the edge over BA on returns for 2026, with the stronger performance.